Join us in celebrating and honoring the up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry.
In order to nominate yourself or someone you think is an Emerging Pharma Leader, first consider the qualities, knowledge, skills, and activities of the nominee. Are they headed for the C-Suite? Do they have what it takes to make the tough decisions that will continue to face manufacturers in the coming years? Can they navigate the commercial, financial, scientific, R&D, marketing, sales, and/or market access with leadership and inspiration? Do they have what it takes to get to the next level?
To review the accomplishments of 2020 winners, read here.
*The deadline for submissions is March 1, 2021*
If you have any questions on the entry process, please contact the organizers by email here.
For the official press release from MJH Life Sciences on the 2021 Emerging Pharma Leaders Awards, click here.
To sign up and submit a nomination, click here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.